A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis

被引：0
|
作者：
Jacqueline E. Paramarta
Maureen C. Turina
Troy Noordenbos
Tanja F. Heijda
Iris C. Blijdorp
Nataliya Yeremenko
Dominique Baeten
机构：
[1] Academic Medical Center/University of Amsterdam,Department of Clinical Immunology and Rheumatology
[2] Academic Medical Center/University of Amsterdam,Laboratory of Experimental Immunology
来源：
Journal of Translational Medicine | / 14卷
关键词：
Spondyloarthritis; Nilotinib; Tyrosine kinase inhibitor; Randomized controlled trial; Mast cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] The tyrosine kinase inhibitor nilotinib inhibits SARS-CoV-2 in vitro
    Cagno, Valeria
    Magliocco, Gaelle
    Tapparel, Caroline
    Daali, Youssef
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2021, 128 (04) : 621 - 624
  • [42] A phase II study of nilotinib, a novel tyrosine kinase inhibitor administered to patients with hypereosiniphilic syndrome (HES).
    le Coutre, Philipp
    Hochhaus, Andreas
    Heim, Dominik
    Rafferty, Teresa
    Weitzman, Aaron
    Zheng, Ming
    Baskaynak, Gokben
    Verhoef, Gregor
    BLOOD, 2006, 108 (11) : 315B - 315B
  • [43] Development of a Kidney Calcification Inhibitor Employing Image-Based Profiling: A Proof-of-Concept Study
    Kletzmayr, Anna
    Bigler, Melina
    Montanari, Elita
    Kuro-o, Makoto
    Hayashi, Hirosaka
    Ivarsson, Mattias E.
    Leroux, Jean-Christophe
    ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2020, 3 (06) : 1339 - 1351
  • [44] IκB kinase inhibition as a potential treatment of osteoarthritis - results of a clinical proof-of-concept study
    Grothe, K.
    Flechsenhar, K.
    Paehler, T.
    Ritzeler, O.
    Beninga, J.
    Saas, J.
    Herrmann, M.
    Rudolphi, K.
    OSTEOARTHRITIS AND CARTILAGE, 2017, 25 (01) : 46 - 52
  • [45] Migraine chronification as an allostatic disorder: a proof-of-concept study
    Calabro, Calogero
    Di Tillo, Eliana
    Pensato, Umberto
    Zenesini, Corrado
    Favoni, Valentina
    Fontana, Camilla
    Cevoli, Sabina
    Tossani, Eliana
    Cortelli, Pietro
    Grandi, Silvana
    Pierangeli, Giulia
    NEUROLOGICAL SCIENCES, 2024, 45 (06) : 2775 - 2782
  • [46] Fully weekly antituberculosis regimen: a proof-of-concept study
    Kort, Fatma
    Le Ray, Laure Fournier
    Chauffour, Aurelie
    Jarlier, Vincent
    Lounis, Nacer
    Andries, Koen
    Aubry, Alexandra
    Guglielmetti, Lorenzo
    Veziris, Nicolas
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56 (03)
  • [47] Prophylactic treatment in menstrual migraine: A proof-of-concept study
    Wickmann, Franziska
    Stephani, Caspar
    Czesnik, Dirk
    Klinker, Florian
    Timaeus, Charles
    Chaieb, Leila
    Paulus, Walter
    Antal, Andrea
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 354 (1-2) : 103 - 109
  • [48] A Monolithic Compliant Continuum Manipulator: A Proof-of-Concept Study
    Thomas, Theodosia Lourdes
    Venkiteswaran, Venkatasubramanian Kalpathy
    Ananthasuresh, G. K.
    Misra, Sarthak
    JOURNAL OF MECHANISMS AND ROBOTICS-TRANSACTIONS OF THE ASME, 2020, 12 (06):
  • [49] Motivated Forgetting in Early Mathematics: A Proof-of-Concept Study
    Ramirez, Gerardo
    FRONTIERS IN PSYCHOLOGY, 2017, 8
  • [50] Migraine chronification as an allostatic disorder: a proof-of-concept study
    Calogero Calabrò
    Eliana Di Tillo
    Umberto Pensato
    Corrado Zenesini
    Valentina Favoni
    Camilla Fontana
    Sabina Cevoli
    Eliana Tossani
    Pietro Cortelli
    Silvana Grandi
    Giulia Pierangeli
    Neurological Sciences, 2024, 45 : 2775 - 2782
12345